These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18534028)

  • 1. Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
    Wang J; Barnes RO; West NR; Olson M; Chu JE; Watson PH
    Breast Cancer Res; 2008; 10(3):R51. PubMed ID: 18534028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
    Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
    Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between SCP3 and JAB1 Confers Cancer Therapeutic Resistance and Stem-like Properties through EGF Expression.
    Oh SJ; Noh KH; Song KH; Kim TW
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A7, Jab1, and p27
    Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
    J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
    Sneh A; Deol YS; Ganju A; Shilo K; Rosol TJ; Nasser MW; Ganju RK
    Breast Cancer Res Treat; 2013 Apr; 138(3):727-39. PubMed ID: 23535840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu.
    Hsu MC; Chai CY; Hou MF; Chang HC; Chen WT; Hung WC
    Mod Pathol; 2008 May; 21(5):609-16. PubMed ID: 18246048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.
    Adams BD; Cowee DM; White BA
    Mol Endocrinol; 2009 Aug; 23(8):1215-30. PubMed ID: 19423651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.
    Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC
    Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
    Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
    Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding.
    West NR; Farnell B; Murray JI; Hof F; Watson PH; Boulanger MJ
    Protein Sci; 2009 Dec; 18(12):2615-23. PubMed ID: 19844956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcr-Abl oncogene stimulates Jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells.
    Yang KT; Wang MC; Chen JY; Hsu MC; Hung WC
    J Cell Physiol; 2011 Nov; 226(11):2849-56. PubMed ID: 21935931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
    Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
    Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
    Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
    Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells.
    Song X; Wei Z; Shaikh ZA
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):26-34. PubMed ID: 26006730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.